1 Top ETF I Plan to Load Up on in 2026

The Schwab U.S. Dividend Equity ETF (SCHD) tracks the Dow Jones U.S. Dividend 100 Index and holds 100 high-yielding dividend growth stocks; its top allocations include Bristol Myers Squibb (4.2% weight, 4.7% yield) and Lockheed Martin (4.1% weight, 2.8% yield). At the last March reconstitution the fund's average holding yielded ~3.8% and delivered an average five-year dividend growth rate of 8.4% annualized; the fund trades at roughly 17x earnings with a ~3.7% yield versus the S&P 500 at >25x earnings and ~1.1% yield. SCHD returned only ~1% in 2025 versus the S&P 500’s >17%, but has delivered >10% annualized over multiple multi-year horizons and the author expects stronger future returns, making the ETF an attractive buy for income-oriented portfolios in 2026.

Analysis

Market structure: The immediate beneficiaries are dividend-focused ETFs (SCHD) and high-quality income names (BMY, LMT, defensive REITs/utilities) as investors rotate from high-P/E growth into 17x-earnings, ~3.7% yield stocks versus S&P at >25x and 1.1% yield. Annual index reconstitution (next March) creates predictable buy pressure for stocks that clear dividend-quality screens (average yield ~3.8% last reconstitution) and supply squeezes for excluded names; expect modest compression of equity risk premia in income names and lower implied vols in large-cap dividend names. Cross-asset: sustained flows to yield equities can cap Treasury demand, pressuring rates up to 25–50bp in stress scenarios and strengthening USD if rate differentials widen.

Risk assessment: Tail risks include a recession-driven wave of dividend cuts (three quarters of holdings could cut if corporate free cash flow falls >20%), a Fed policy surprise (hawkish hike or dovish cut) within 3 months, or geopolitical shocks hitting defense names. Near-term (days–weeks) effects will be flow-driven (reconstitution/window-dressing), medium-term (months) tied to CPI/Fed, long-term (quarters–years) tied to dividend growth sustainability. Hidden dependency: dividend health correlates with buyback programs and sector cyclical revenues (pharma, defense), so headline yields can mask cash-flow fragility. Catalysts: Fed prints, FY2026 budget votes, and March reconstitution will accelerate positioning.

Trade implications: Direct: initiate a tactical 2–3% long in SCHD for 12–18 months, and 1–2% long positions in LMT and BMY for defensive yield; size buys into >2% intraday dips. Pair: run a beta-neutral long SCHD / short SPY ratio ~1.0:0.8 for 6–12 months to harvest yield tilt; unwind if SPY outperforms SCHD by >8% over 90 days. Options: sell covered calls on SCHD to add 2–4% yield, and buy 9–12 month 5–7% OTM puts sized 15–25% notional as crash protection.

Contrarian angles: The consensus underprices the risk that dividend names can outperform if rates stabilize—valuation gap (17x vs 25x) is mean-reverting over 12–24 months. Conversely, the market may be underestimating clustering risk at the March reconstitution: crowding could create short-term liquidity squeezes and price gaps for mid-cap dividend names. Historical parallel: 2013–2014 rotation into value/dividend after rate shocks produced multi-year outperformance; if corporate cash flows deteriorate, however, dividend-focused ETFs will lag sharply, so size positions with active rebalancing and dividend-health screens.

Key Decisions for Investors

• Establish a 2–3% portfolio weight in SCHD by end-February 2026, accumulate on any >2% pullback; target a 12–18 month hold and a stop-loss at -12% absolute or if fund yield compresses below 3.2% on sustained basis (>30 days).
• Implement a beta‑neutral pair: long SCHD (2.0% NAV) and short SPY (1.6% NAV, ~0.8x) for 6–12 months to capture yield/valuation reversion; close if SPY outperforms SCHD by >8% over a rolling 90-day window or if 10‑yr Treasury >4.25% persistently for 30 days.
• Initiate 1–2% long positions in LMT and BMY (split as preferred) for defensive dividend exposure; enhance income by selling 6–12 month covered calls roughly 10–20% OTM to generate incremental 3–5% annualized premium while retaining dividends.
• Use options hedges: buy 9–12 month puts on SCHD (5–7% OTM) sized at 15–25% notional to protect against >10% market drawdowns; alternatively sell monthly 25–35% OTM covered calls on SCHD to boost cash yield by ~2–4% annualized.
• Trim 3–5% exposure to high‑P/E, low‑yield mega caps (e.g., NVDA/NFLX) and redeploy into SCHD/LMT if 10‑yr Treasury rises >25bp from current levels or S&P forward P/E remains >22 for >30 days; monitor CPI/Fed announcements over next 90 days as re-rating triggers.